Robert Michiels
Director/Board Member at Embolization Prevention Technologies
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Starling | M | 70 |
Aegis Surgical Ltd.
 Aegis Surgical Ltd. Medical SpecialtiesHealth Technology Aegis Surgical Ltd. develops healthcare equipment for the treatment of symptomatic aortic stenosis. The company was founded by William N. Starling Jr. and is headquartered in Dublin, Ireland.
Atrius Ltd.
 Atrius Ltd. Medical/Nursing ServicesHealth Services Atrius Ltd. operates a healthcare center. The company is based in Ledbury, UK. The British company was founded in 2003 by William N. Starling, who has been the CEO since 2003. | 11 years |
| Matthieu de Beule | M | - |
FEops NV
 FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | 15 years |
| Euan Stuart Thomson | M | 60 |
FEops NV
FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | 3 years |
| Peter Mortier | M | - |
FEops NV
FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | 15 years |
| Frederik Justin Gabriel Groenewegen | M | - |
415 Capital Management GmbH
 415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | 6 years |
| Frank Gabriel Groenewegen | M | - |
415 Capital Management GmbH
415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | 6 years |
| David P. Thompson | M | - |
415 Capital Management GmbH
415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | 6 years |
| Jean-Claude Laborde | M | - |
415 Capital Management GmbH
415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | - |
| Michael Braun | M | - |
415 Capital Management GmbH
415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | 5 years |
| Linus Rieder | M | - |
415 Capital Management GmbH
415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | 5 years |
| Azin Parhizgar | M | 64 |
415 Capital Management GmbH
415 Capital Management GmbH Investment ManagersFinance 415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany. | 4 years |
| Guillaume Darnand | M | - |
FEops NV
FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | - |
| Tom Fleming | M | - |
FEops NV
FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | 6 years |
| Jose Calle Gordo | M | - |
FEops NV
FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | 5 years |
| Alexandra Tolia | M | - |
FEops NV
FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | - |
| Marc Lambrechts | M | - |
FEops NV
FEops NV Medical SpecialtiesHealth Technology FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium. | - |
| Michael Charles France | M | 77 |
Atrius Ltd.
Atrius Ltd. Medical/Nursing ServicesHealth Services Atrius Ltd. operates a healthcare center. The company is based in Ledbury, UK. The British company was founded in 2003 by William N. Starling, who has been the CEO since 2003. | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul A. Cornelison | M | 59 |
Edwards Lifesciences CardiaQ LLC
 Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA. | - |
| David Bonita | M | 48 |
Edwards Lifesciences CardiaQ LLC
Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA. | - |
| Vince Burgess | M | 59 |
Edwards Lifesciences CardiaQ LLC
Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA. | 4 years |
| Mark Vreeke | M | - |
Edwards Lifesciences CardiaQ LLC
Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA. | 9 years |
| Tak Cheung | M | - |
Edwards Lifesciences CardiaQ LLC
Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 8 | 36.36% |
| Germany | 7 | 31.82% |
| United States | 5 | 22.73% |
| United Kingdom | 2 | 9.09% |
| Ireland | 1 | 4.55% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Michiels
- Personal Network
